The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis

The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis

Even though S-1 is a widely used chemotherapeutic agent, there is no evidence for its use in an adjuvant setting for biliary tract carcinoma (BTC). Patients who underwent surgical treatment for BTC between August 2007 and December 2018 were selected. Propensity score matching was performed between p...

Full description

Bibliographic Details
Main Authors: Yoichi Miyata, Ryota Kogure, Akiko Nakazawa, Rihito Nagata, Tetsuya Mitsui, Riki Ninomiya, Masahiko Komagome, Akira Maki, Nobuaki Kawarabayashi, Yoshifumi Beck
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
adjuvant chemotherapy
biliary tract carcinoma
propensity score matching
retrospective
S-1
Online Access:https://www.mdpi.com/2077-0383/10/5/925

Internet

https://www.mdpi.com/2077-0383/10/5/925

Similar Items